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Summary 
In five members of a family and another unrelated per- 
son affected by a slow-channel congenital myasthenic 
syndrome (SCCMS), molecular genetic analysis of ace- 
tylcholine receptor (AChR) subunit genes revealed a 
heterozygous G  to A mutation at nucleotide 457 of the 
a subunit, converting codon 153 from glycine to serine 
(aG153S). Electrophysiologic analysis of SCCMS end 
plates revealed prolonged decay of miniature end plate 
currents and prolonged activation episodes of single 
AChR channels. Engineered mutant AChR expressed 
in HEK fibroblasts exhibited prolonged activation epi- 
sodes strikingly similar to those observed at the 
SCCMS end plates. Single-channel kinetic analysis of 
engineered aG153S AChR revealed a markedly de- 
creased rate of ACh dissociation, which causes the 
mutant AChR to open repeatedly during ACh occu- 
pancy. In addition, ACh binding measurements com- 
bined with the kinetic analysis indicated increased de- 
sensitization of the mutant AChR. Thus, ACh binding 
affinity can dictate the time course of the synaptic re- 
sponse, and aG153 contributes to the low binding af- 
finity for ACh needed to speed the decay of the synap- 
tic response. 
Introduction 
Congenital myasthenic syndromes (CMS) are inherited 
disorders in which the safety margin of neuromuscular 
transmission is compromised by one or more specific 
mechanisms. The CMS recognized to date are attributed 
to an abnormality in the resynthesis or vesicular packaging 
of acetylcholine (ACh), a paucity of synaptic vesicles and 
reduced quanta1 release, end plate (EP) ACh esterase 
(AChE) deficiency, and postsynaptic defects associated 
with 2 kinetic abnormality or deficiency of the ACh receptor 
(AChR) (Engel, 1994). We previously hypothesized that a 
kinetic abnormality of AChR predicts a mutation in one 
or more of its subunits (Engel, 1993; Engel et al., 1993). 
Subsequently, we traced two CMS caused by prolonged 
AChR channel openings to 2 mutation in the M2 trans- 
membrane domain of the E subunit (Ohno et al., 1995a, 
1995b). To test our hypothesis further, we searched for 
the mutational basis of 2 slow-channel CMS (SCCMS) pre- 
viously observed in two families and a sporadic case (En- 
gel et al., 1982). Here we report the discovery of a mutation 
in the a subunit gene of AChR in one of the SCCMS fami- 
lies and the sporadic case and analyze the pathogenic 
effects of the mutation on functional properties of AChR. 
The effects of the mutation on AChR function demonstrate 
the importance of ACh binding affinity in dictating the time 
course of the synaptic response. Moreover, the location 
of the mutation provides structural insight into determi- 
nan?s of ACh binding affinity. 
Results 
Electrophysiologic Studies of SCCMS 
EPs from Patient 2 
Miniature EP currents (MEPCs) recorded from SCCMS 
EPs were of normal amplitude but had 2 markedly pro- 
longed decay (Figure 1, upper traces). At all 11 EPs stud- 
ied, the decay was biexponential, with one decay time 
constant 2.4-fold and the other a-fold prolonged (Table 1). 
These observations indicate the presence of at least two 
kinetically distinct types of AChR at the SCCMS EP. 
Power spectra of ACh-induced current noise were best 
fitted by the sum of two Lorentzians, one close to normal 
and the other 5-fold longer than normal, consistent with 
two open channel durations (Table 1). 
Patch-clamp recordings obtained from SCCMS EPs re- 
vealed markedly prolonged episodes of AChR channel 
openings over 2 range of ACh concentrations (50 nM to 
10 PM; Figure 1, lower traces). These channel events, like 
more than 99% of events at control EPs, had a mean 
conductance of 60 pS. Approximately 4% of events de- 
tected at SCCMS EPs had 2 reduced conductance of 45 
pS and prolonged open durations typical of AChRs con- 
taining the y subunit instead of the E subunit (Mishina et 
al., 1986). At 50 nM ACh, channel activity was uniformly 
distributed over the first 60 s of recording, but at higher 
concentrations, channel openings occurred in clusters 
separated by silent periods of 0.3-10 s, consistent with 
desensitization (Sakmann et al., 1980). Control EPs, by 
contrast, showed no clear clustering of openings at con- 
centrations up to I PM ACh. 
Analysis of open interval durations revealed no differ- 
ences between SCCMS and control EPs; a brief first and a 
longer second component had time constants and relative 
areas similar to those in normal controls (Table 2). Analysis 
of burst durations, however, revealed a markedly pro- 
longed component of bursts at 6 of 7 SCCMS EPs, in 
addition to two brief components that were similar to those 
deiected in normal controls (Table 2). The overall results 
from MEPC, ACh-induced current noise, and patch-clamp 
recordings indicate at least two types of AChR channels 
at the SCCMS EP: those that activate in episodes of ap- 
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Control Patient Figure 1. Comparison of MEPCs and Channel 
Events Recorded from Control and SCCMS EP 
Upper traces, MEPCs; lower traces, channel 
events; left control; right, SCCMS EP. 
Note markedly prolonged decay of the MEPC 
and presence of some markedly prolonged 
channel events in the SCCMS. The MEPC de- 
cay phase is best fitted by the sum of two expo- 
nentials. Vertical arrows indicate MEPC decay 
time constants. MEPCs were filtered at 500 Hz 
and single-channel currents at 12 kliz. T = 
22oc k 0.5% 
proximately normal duration and those that activate in 
markedly prolonged episodes. 
Mutational Analysis 
Patient 1, a familial case, and patient 3, a sporadic case, 
were previously described as patients 4 and 3 in the first 
description of the SCCMS (Engel et al., 1982). 
We first screened for the genetic basis of the SCCMS 
in patient 1 by single-strand conformation polymorphism 
(SSCP) analysis on amplified fragments of DNA encoding 
the a, 8, 6, and E subunits. We detected five aberrant 
conformers; four of these were commonly observed even 
in controls and were proven to be due to polymorphisms, 
but one was unique to the patient. Direct sequencing of 
the corresponding DNA fragments identified the four poly- 
morphisms: 8A26G, predicting f3ESG, in 6 exon 2; 6A-52G, 
predicting SP-18P, in the signal peptide-encoding region 
of 6 exon 1; ~C857+15G in E intron 8, 15 bases down- 
stream from the last base of exon 8; and ~C1233T, pre- 
dicting ~A41 1 A, in E exon 11. The aberrant conformer 
unique to the patient was due to a heterozygous G  to A 
mutation in a exon 5 at nucleotide 457 (aG457A) that con- 
verted the codon at position 153 encoding glycine to a 
codon encoding serine (aG153S) (Figure 2A). The altered 
amino acid residue is in the amino-terminal extracellular 
domain of the a subunit, is unique to the a subunit, and 
is highly conserved among the a subunits of other species 
(Figure 2C). 
The aG457A mutation resulted in gain of an Alul restric- 
tion site, allowing identification of carriers by analysis of 
PCR fragments derived from genomic DNA. Alul digestion 
of DNA samples obtained from other family members re- 
Table 1. Analvsis of MEPCs and of ACh-Induced Current Norse 
vealed that all five affected and no unaffected relatives 
harbored the aG153S mutation. Thus, the aG153S muta- 
tion cosegregates with the SCCMS phenotype in the family 
(Figure 28). Restriction analysis detected no similar muta- 
tion in DNA samples of 100 normal controls. 
Restriction analysis of genomic DNA specimens ob- 
tained from 29 other unrelated CMS patients revealed 
another aG153S mutation, in a sporadic case of the 
SCCMS (patient 2 in this report). SSCP analysis of ampli- 
fied DNA fragments of patient 2 revealed three aberrant 
conformers. On direct sequencing of the corresponding 
DNA fragments, one of the aberrant conformers proved 
to be due to the aG153S mutation. The second one was 
due to SA-52G, predicting 6P-18P, in 6 exon 1 (as in 
patient 1). The third aberrant conformer was accounted 
for by two polymorphisms in E intron 11: E1266+10del20 
and EGO 266+33C. 
To exclude the possibility that the aG153S mutation was 
only a linkage marker associated with an unidentified 
pathogenic mutation in the a subunit that SSCP analysis 
might have missed, we sequenced the entire open reading 
frame of the a subunit in both patients, using cDNA frag- 
ments of patient 1 and genomic DNA fragments of patient 
2. No other mutations were detected. 
Expression Studies 
To confirm pathogenicity of aG153S and to allow studies 
of its mechanism of action, we engineered the mutation 
into the a subunit cDNA of mouse AChR and coexpressed 
the mutant a subunit with wild-type, 8, E, and 6 subunits 
in 293 HEK fibroblasts. Measurements of a-bungarotoxin 
binding revealed approximately 50% of surface AChR ex- 
pressed by the mutant subunit relative to the wild-type 
subunit. We then recorded single-channel currents and 
measured binding of ACh to give an overall mechanistic 
description of the aG153S AChR. 
9-10 Controls Patient 2 
hEPC (ms) 3.23 f 0.50 (78) T, = 7.8 + 2.9 (11) 
~2 = 26.4 f 3.3 (11) 
5,a,re (ms) 2.30 k 0.31 (52) T, = 1.8 f 0.42 (10) 
~2 = 12.3 5 1.95 (10) 
Values Indicate mean + SD; number of EPs indicated in parentheses. 
a For the 11 SCCMS EPs, the fast and slow components accounted 
for 48% + 5.7% and 52% -c 5.7% of the peak MEPC amplitude. 
Patch Recordings from HEK Cells 
at Low ACh Concentrations 
Figure 3 compares single-channel currents elicited by low 
concentrations of ACh (50-300 nM) for wild-type and 
aG153S AChRs expressed in 293 HEK cells. Currents 
were recorded at 12-14 kHz bandwidth to resolve the fine 
structure of opening and closing events. The wild-type 
Table 2. Open Intervals and Bursts of 60 pS Channels at Control and Patient Endplates 
Open intervals Bursts 
Controls Patient Controls Patient 
T] (ms) 0.20 2 0.12 0.23 f 0.12 0.15 t 0.11 0.14 f 0.041 
Area 0.16 + 0.085 0.15 + 0.054 0.16 f 0.074 0.24 + 0.096 
Number of EPs 32 11 32 11 
~~ (ms) 1.90 f 0.50 1.87 f 0.23 2.82 k 0.93 3.40 * 1.83 
Area 0.85 k 0.093 0.85 + 0.053 0.85 k 0.082 0.33 f 0.19 
Number of EPs 34 11 34 10” 
~~ (ms) ND ND ND 13.25 f 4.89 
Area ND ND ND 0.47 f 0.19 
Number of EPs 11 
Values indicate means f SD. Recordings from SCCMS EPs were in the presence of 0.05 PM ACh (5 EPs), 0.1 PM ACh (2 EPs), and 1 PM ACh 
(4 EPs). The dwell times and areas of open intervals and bursts were not significantly different at these concentrations. Recordings from control 
EPs were in the presence of 1 PM ACh. ND, not detected. 
a The second component of bursts was present only at patches of 10 SCCMS EPs. Potential = -80 mV; T = 22OC + 0.5”C. 
AChR opens from one to several times per activation epi- 
sode, whereas the mutant AChR exhibits markedly pro- 
longed activation episodes, apparently owing to increased 
numbers of openings per episode. This pattern of open- 
ings of the expressed mutant AChR is strikingly similar to 
that observed at the SCCMS EP (see Figure 1). For both 
the wild-type and mutant AChR, closed duration histo- 
grams exhibit a long duration component associated with 
periods between independent activation episodes and a 
brief component associated with closely spaced openings 
of a single channel (Figure 3). Increased reopening of the 
mutant AChR gives rise to increased area of the brief 
closed duration component relative to that of the long dura- 
tion component. 
We constructed burst duration histograms by defining 
a burst as a series of openings separated by a specified 
closed time (100 KS for wild-type and 150 p.s for aG153S 
AChR; see Experimental Procedures). Both wild-type and 
mutant AChRs show two components of bursts (Figure 
3). The brief component corresponds to isolated single 
openings because its time constant issimilar in histograms 
of all openings and of bursts. These solitary openings may 
correspond to AChRs with a single bound agonist because 
their f requency of occurrence decreases at raised ACh 
concentrations (Colquhoun and Sakmann, 1985; see be- 
low). The remaining long duration component is due to 
bursts of closely spaced openings, corresponds to AChRs 
with two bound agonists, and is prolonged approximately 
15-fold in the aG153S AChR. 
We analyzed measurements obtained at low ACh con- 
centrations according to the following standard kinetic 
scheme: 
k,l\ k+Z A+R-AR+A+A>R B, T AZR' (scheme 1) kI “2 
where two agonists A bind to the receptor R  with 8SSOCi8- 
tion rates k+, and k+2 and dissociate from the receptor with 
rates k-, and kmO, Fully occupied receptors AzR open with 
rate p, and open receptors ApR* close with rate a. If brief 
closings at low agonist concentration correspond to dwells 
in A2R, they are predicted to decay with a time Constant 
equal to (p + k-*)-j and to occur p/k-* times per burst of 
openings (Colquhoun and Hawkes, 1981). Using these 
relationships, b and km2 have been estimated from low 
concentration measurements for AChRs from several spe- 
cies (Colquhoun and Sakmann, 1985; Sine et al., 1990). 
In the present work, both wild-type and mutant AChR show 
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Figure 2. Mutational Analysis of AChR in SCCMS 
(A) Automated sequencing of a exon 5 around codon 153 in patient 
1 and in a control. In the patient, both A and G nucleotides are present 
at position 457, indicating heterozygous G to A transition. This muta- 
tion changes codon 153 from a GGC for glycine to an AGC for serine. 
(B) Restriction analysis using genomic DNA from blood of family 1. 
The wild-type allele yields two fragments of 107 and 48 bp; the mutant 
allele gives rise to three fragments of 84, 48, and 23 bp. Both the 
mutant 84 bp fragment (upper closed arrowhead) and the wild-type 
107 and 48 bp fragments (open arrowheads) are observed in the five 
affected family members (closed symbols). The mutant 23 bp fragment 
(lower closed arrowhead) is barely visible in the figure. The index pa- 
tient is shown by an arrow. 
(C) Multiple alignment of extracellular domain of AChR subunits 
around codon 153. Box encloses the conserved glycine residue in 
AChR a subunits of other species. Torpedo c., Torpedo californica; 
Torpedo m., Torpedo marmorata. 
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Bursts Wild Type 
log Duration (s) 
Figure 3. Analysis of Currents Elicited by Low Concentrations of ACh for Weld-Type and aG153S AChRs 
(Left) Currents elicited by 100 nM (wild type) or 50 nM (aG153S) ACh filtered at 12 kHz. Channel openings are upward deflectrons. 
(Center) Closed duratron histograms fitted by the sum of exponentials. Wild type: rfaJt = 10.6 t~s, a,.,, = 0.52, ~~~~~ = 0.18 s, total detected events, 
1791; aG153.S: rfar, = 15.9 us, afar, = 0.90, rslou = 0.45 s, total detected events, 1798. 
(Right) Burst duration histograms fitted by the sum of exponentials. Wild type: 70 = 86.7 us, a0 = 0.25, rburr, = 1.47 ms, total number of bursts, 
1059; aG153S: r[o = 172 +s, & = 0.68, rb”,ai = 16.9 ms, total number of bursts, 134. 
only one brief closed duration component at low ACh con- 
centrations, so this component can be associated with 
dwells in the AR closed state. 
Table 3 summarizes measured parameters and com- 
puted rate constants for wild-type and mutant AChRs. The 
major effect of aG153S is to increase the number of brief 
closings per burst 15-fold, with only a 1.5-fold increase in 
the time constant of the brief closed time component. 
These measured parameters predict a decrease in the 
apparent kmp from 37,000 s-l to 2800 sP and no change 
in 8. The k-* estimate is “apparent” because it is not statisti- 
cally weighted for the number of binding sites. In both 
wild-type and mutant AChFi, 8 is estimated to be very fast, 
50,000-80,000 s-l, and is similar to that obtained from 
single-channel kinetic analysis of Torpedo AChR (Sine et 
al., 1990) and to that from fast ACh application experi- 
ments with mouse AChR (Liu and Dilger, 1991; Macono- 
chic and Steinbach, 1992, Biophys. Sot. Am. Sot. Bio- 
them. Mol. Biol., abstract). The increased time constant 
of brief closings in the aG153S AChR thus results from 
a decreased rate of ACh dissociation. The channel closing 
rate a is only slightly decreased in the mutant, so the equi- 
librium constant for channel gating is not greatly affected. 
Thus, aG153S predominantly affects ACh binding steps; 
it decreases the rate of ACh dissociation from at least one 
of the two binding sites. 
Patch Recordings at Raised ACh Concentrations 
To determine the effect of aG153S on the remaining rate 
constants in scheme 1, we recorded currents at a series 
of raised ACh concentrations; these measurements also 
test consistency of 8, k-*, and a obtained from low concen- 
tration measurements. Raised ACh concentrations allow 
individual rate constants to be estimated because they 
cause events from a single channel to cluster into identifi- 
able activation episodes (Sakmann et al., 1980). Figure 4 
shows an example of such a cluster from wild-type AChR 
in the presence of 20 uM ACh. At the start of the cluster, 
a single AChR channel has just recovered from the desen- 
sitized state and, during the cluster, makes transitions 
among activatable states. A desensitized state can be in- 
corporated into scheme 1 as follows 
(scheme 2) 
i’.+ A - AR'+ A+ A,R' 
5i-- KK 
where R and R’ represent AChRs in the activatable and 
desensitized states, respectively, and M is their ratio in 
the absence of ACh, R’/R. The upper portion of scheme 
2 is equivalent to scheme 1, except ACh is allowed to bind 
to the two sites independently. We use this more general 
treatment for analysis of recordings at high ACh concen- 
trations because it accounts for a fourth closed duration 
component expected in cases in which the binding sites 
have neither identical nor widely separated affinities for 
ACh. The lower portion of scheme 2 depicts ACh binding 
to asingle high affinity desensitized state with dissociation 
constant KR,, which is consistent with the single affinity 
observed in our binding measurements (see below; see 
also Sine and Claudio, 1991). At raised ACh concentra- 
tions, the AChR is predominantly desensitized because Kr+ 
is much smaller than dissociation constants for activatable 
states (i.e., k-,/k+, and k-2/k+2). Channel events cluster be- 
cause transitions between the R and R’ states are slow 
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Table 3. Low ACh Concentration Kmetrc Parameters and Derived Rate Constants 
Number of Closings 
Patches hs, (IIS) a,,,, burst (ms) per Burst S(s ‘) k-z (s ‘) a@ ‘) 
Wild-type AChR 3 10.9 k 0.5 0.536 k 0.038 1.33 ? 0 17 1 46 + 0.12 54,697 ? 4,290 37,530 f 1,660 1,660 + 340 
(100-300 nM 
ACh) 
eG153S AChR 2 16.4 + 07 0.888 2 0014 16.0 + 1.5 21.2 + 3.7 58,990 * 3,300 2,610 f 330 1,399 * 96 
(50 nM ACh) 
rilr, is the time constant of the rapidly decaying closed duration component, a laS, is the corresponding relative area, and rburr, is the mean burst 
duration as defined rn the text. Mean values and standard deviations are grven for each parameter. 
compared with transitions among R states. To compute 
transition rate constants between R states, we used stan- 
dard Q-matrix methods to compute the probability of ob- 
serving each experimental dwell time given a set of trial 
rate constants (Colquhoun and Hawkes, 1977; Ball and 
Sansom, 1989). Optimal transition rate constants were 
taken as those that best described observed dwell t imes 
within clusters. 
Figure 4 shows clusters of openings from aG153S 
AChRs elicited by a range of ACh concentrations. Open- 
ings cluster at concentrations as low as 0.3 uM, unlike 
openings of wild-type AChR, which begin to show cluster- 
ing at about 5 uM ACh. As the concentration of ACh is 
increased, openings within clusters show progressively 
tighter packing, which is paralleled in the closed duration 
histograms where the major class of long duration closings 
moves to shorter time (Figure 4). The open duration histo- 
grams, in contrast, do not change with ACh concentration, 
as expected from scheme 2. For comparison, we analyzed 
currents from wild-type AChR at the single ACh concentra- 
tion of 20 uM (Figure 4) a concentration that produces 
clear clusters and allows occupancy of each activatable 
closed state. 
To determine rate constants from scheme 2, the likeli- 
hood of obtaining each observed open and closed dwell 
time was calculated for a given set of trial rate constants- 
The likelihoods were then summed over all events and 
maximized by iteratively changing the trial rate constants. 
For the aG153S AChR, essentially the same rate con- 
stants were obtained in every patch at every ACh concen- 
tration, so data obtained at all three raised ACh concentra- 
tions were analyzed together. For the wild-type AChR at 
20 PM, some variation in rate constants was observed in 
different patches, requiring separate analysis of data from 
each patch. For analysis of the aG153S AChR, we allowed 
all six rate constants to vary, but for analysis of wild-type 
AChR, we found it necessary to hold f3 constant to the 
value obtained from the low concentration measurements 
(Table 3). The smooth curves overlying the histograms are 
probability density functions computed from the optimal 
rate constants determined by maximum likelihood fitting. 
Analysis of recordings from the aG153S AChR yielded 
well-defined rate constants that describe open and closed 
duration histograms at all three ACh concentrations (Fig- 
ure 4; Table 4). At 0.3 PM and 1 PM ACh, major closed 
duration components predicted by scheme 2 appear as 
40 closed open 
20: , \ 
Figure 4. Analysis of Currents Elicited bY 
Raised Concentrations of ACh for Wild-Type 
and aG153S AChRs 
(Left) Examples of channel openings within 
clusters elicited by the indicated concentra- 
tions of ACh for wild-type and aG153S AChRs. 
(Center and Right) Closed and open duration 
histograms from single patches fitted ac- 
cording to scheme 2. For each type of AChfl, 
the smooth curves are fits to the data with rate 
constants given in Table 4; for aG153S, the 
curves are global fits to all the data. For wild- 
type AChR, the data and fitted rate constants 
correspond to the first patch in Table 4, where 
k+, and km, are well defined. For wild type, the 
total number of openings and closings were 
42,690 for this patch. For aG153S, total open- 
ings and closings for each patch were as fol- 
lows: 0.3 PM, 3496; 1 nM, 5802; 10 PM, 434. 
log duration (s) 
discrete peaks, whereas at 10 PM, they are compressed 
into a major peak and a small, broad shoulder. A single 
dominant open duration component is observed at all 
three ACh concentrations, as predicted by scheme 2. 
Analysis of recordings from wild-type AChR yielded well 
defined rate constants for one of the three patches at 20 
PM ACh (Figure 4; Table 4). These rate constant estimates 
indicate significantly different affinities of the two binding 
sites for ACh, as previously described for AChRs con- 
taining they subunit (Sine et al., 1990; Zhang et al., 1995). 
Analysis of data from the remaining two patches did not 
allow unique assignment of k,, and k-, (Table 4) although 
estimates of these constants obtained from the first patch 
predict a component in the other two patches that would 
be obscured by the major component of closed times. The 
major difference among patches appears to be k,,, which 
determines the position of the major peak of closed times 
and thus whether the less abundant briefer closed times 
that define k+, and km, can be distinguished from this major 
peak. Our estimates of k+? and kmP were well defined in 
each patch and indicate approximately a P-fold range of 
KD for wild-type AChR. Estimates of KP for the aG153S 
AChR lie well outside this range, indicating markedly in- 
creased affinity of ACh for this site (Table 4). 
The effect of aG153S on activation rate constants in 
scheme 2 is summarized in Table 4. As demonstrated by 
analysis of recordings obtained at low ACh concentra- 
tions, the rate constant for ACh dissociation from one of 
the two binding sites is markedly slowed in aG153S. The 
sum of dissociation rate constants for the two sites (2237 
s-‘) is close to the apparent rate constant obtained at low 
ACh concentrations (2810 s-‘; Table 3) as expected. The 
experimental counterpart of this decreased kmP is the in- 
creased fraction of brief closings observed in all the data 
obtained over a wide range of ACh concentrations. Thus, 
in aG153S AChR, the rates of ACh dissociation from the 
two sites are slow and essentially equal, whereas in wild- 
type AChR, dissociation from at least one site is fast. As- 
sociation rate constants are also affected by aG153.B 
increasing by approximately 1 O-fold (Table 4). The experi- 
mental correlates of faster association are closed time 
components with means of approximately 100 ms and 10 
ms at 0.3 W M  and 1 FM ACh, respectively, concentrations 
that produce much longer closed times in wild-type AChR. 
For both wild type and aG153S, estimates of the channel 
gating rate constants, 8 and a, are similar in both the high 
and the low ACh concentration analyses. Thus, as con- 
cluded from analysis of recordings obtained at low ACh 
concentrations, aG153S primarily affects ACh binding 
steps. 
Measurements of Equilibrium ACh Binding 
To gain an overall mechanistic picture of the effect of 
aG153S, we measured equilibrium binding of ACh bycom- 
petition against the initial rate of a-bungarotoxin binding 
(Sine and Taylor, 1979). aG153S shifts the concentration 
dependence of equilibrium ACh binding approximately 40- 
fold toward lower concentrations while maintaining co- 
operativity with a Hill coefficient of 1.45 (Figure 5A). Because 
both activatable and desensitized receptors contribute to 
equilibrium binding, we next measured the affinity of the 
desensitized receptor for ACh, with the aim of combining 
parameters of both activation and desensitization to 
describe equilibrium ACh binding. 
Previous work established that local anesthetics convert 
the AChR to a state whose affinity coincides with that of the 
desensitized state (Weiland et al., 1977; Sine and Taylor, 
1982). We therefore measured ACh binding in the pres- 
ence of a range of concentrations of the local anesthetic 
proadifen (Sine and Claudio, 1991). For both aG153S and 
wild-type AChRs, 60-100 bM proadifen shifts the binding 
curve to lower ACh concentrations and decreases the Hill 
coefficient to unity, indicating binding to a single class of 
high affinity sites (Figures 58 and 5C). We tested higher 
concentrations of proadifen to determine whether the shift 
was maximal but found no further shift of the curve. For 
wild-type AChR, the proadifen-induced shift is 55-fold, 
whereas for aG153S AChR, the shift is only 8-fold. Thus, 
for the aG153S AChR, the equilibrium binding curve lies 
closer to that for binding solely to the desensitized state. 
Taking the midpoint of each curve as KR’ in scheme 2, 
the affinity of the desensitized state is seen to increase 
approximately 6-fold in aG153S (Table 4). 
The smooth curves overlying the equilibrium binding 
Table 4. Comparison of Scheme 2 Parameters for Wild Type and aG153S 
Number of KI 
Patches k+r k-1 W, k+2 ks :M, P  fl Kw W W  M  
Wtld-type AChFi 1 84 210 2.5 18 
(k 23) (+ 131) (* 1) 
(20 pM ACh) 1 ND ND 
(“: 5) 
1 ND ND :: 1) 
uG153S AChR 4 788 1,267 1.6 95 
(0.3-10 uM ACh) (.t 148) (? 109) (2 12) 
16,457 914 
(* 209) 
18,152 586 
(k 319) 
11,220 510 
(T 526) 
970 10.2 
(k 98) 
60,000 2,288 0.040 3.0 x 10-d 
(2 15) (2 0.004) (k 0.18 x lo-‘) 
60,000 2,375 
(2 26) 
60,000 2,512 
(2 59) 
44,965 883 0.006 1.5 x 10-Z 
(k 790) (k 16) (+ 0.0004) ( * 0.29 x 10-Z) 
For each rate constant, the value in parenthesis is the error limit estimated by the half likelihood interval method (Colquhoun and Sigworth, 1983); 
rate constants without errors were fixed in the fitting. Rate constants not uniquely defined by the data are indicated by ND. Association rate 
constants are in units of uM-’ s-‘, whereas all others are in s ‘. Kn, is the dissociation constant of the desensitized state for ACh, and M  is the 
ratio of desensitized to activatable AChRs at rest. Values under Kn, and M  are means and standard deviations. For the aG153.S AChR, the rate 
constants were determined from a global fit to the data from all four patches. 
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Figure 5. Acetylcholine Binding at Equilibrium to Wild-Type and 
aG153S AChRs 
(A) Comparison of ACh binding to wild-type and aG153S AChRs. 
The curves are fits to the Hill equation with the following parameters: 
wild type, K,,,, = 1.9 NM, n, = 1.26; uGl53S, b”,,= 0.051 PM, 
nH = 1.45. 
(6) ACh binding to wild-type AChR in the absence and the presence 
of a saturating concentration of the local anesthetic proadifen. The 
curve through the closed squares (+I00 PM proadifen) is drawn ac- 
cording to scheme 2 with the activation parameters given in Table 4, 
KR. equal to GU,, for these data, and M  = 1000. The curve through 
the open squares (no additions) is drawn according to scheme 2 with 
the activation parameters given in Table 4 (KI and Kz values of 2.5 
and 914 uM, respectively), Kn equal to GU,, for the 100 aM proadifen 
data, and M  determined by least squares fitting (Table 4). The curve 
to the right represents the theoretical curve for binding solely to activa- 
table states and is drawn according to scheme 2 with parameters given 
in Table 4 (K, and KP values of 2.5 and 914 FM, respectively) and 
M  = 0. Because K, was uniquely determined for one of three patches 
(Table 4) we tested a range of KI values, and found values of 2 NM 
to 10 aM to fit the binding data equally well, with similar fitted values 
of M. 
(C) ACh binding to aG153S AChR in the absence and the presence of 
a saturating concentration of proadifen. The curve through the closed 
squares (+60 W M  proadifen) is drawn according to scheme 2 with the 
activation parameters given in Table 4 (K1 and K2 values of 1.6 and 
10.2 uM, respectively), KR. equal to KBqUll for these data, and M  = 1000. 
The curve through the open squares (no additions) is drawn according 
to scheme 2 with the activation parameters given in Table 4, Kn equal 
to G4., for the 60 aM proadifen data, and M  determined by least 
squares fitting (Table 4). The curve to the right represents the theoreti- 
cal curve for binding solely to activatable states and is drawn according 
to scheme 2 with parameters given in Table 4 and M  = 0. 
profiles were obtained by fitting the theoretical binding 
function for scheme 2 to the binding data (Figures 56 and 
5C). Because the theoretical binding function contains too 
many parameters to allow a unique fit to the binding data 
alone (see equation 1 in Experimental Procedures), we 
assigned as many parameters as possible to values ob- 
tained from independent measurements. The activation 
parameters were assigned to values obtained from single- 
channel kinetic analysis (Table 4) and the desensitization 
dissociation constant to that determined from the local 
anesthetic experiments. Thus, the only free parameter in 
the fit was the constant M, the ratio of desensitized to 
activatable AChRs at rest. Additional pathways between 
activatable and desensitized states can be incorporated 
into scheme 2 without affecting its applicability to binding 
data obtained at equilibrium; the equilibrium constants for 
these pathways would be defined, through microscopic 
reversibility, by the parameters shown in scheme 2. A dis- 
tinguishing feature of scheme 2 is the concerted switch 
of the two binding sites from activatable to desensitized 
states, which gives rise to cooperativity in the equilibrium 
binding curve. For both wild-type and aG153S binding 
curves, both the midpoint and the degree of cooperativity 
are well described by scheme 2. The fitted M is a small 
number for both receptor types, but it increases about 
50-fold in aG153S, indicating increased propensity for de- 
sensitization. 
The increased propensity for desensitization by the 
aG153S AChR can be illustrated by defining a concentra- 
tion window corresponding to the range of possible equilib- 
rium ACh binding profiles. The right boundary of the win- 
dow corresponds to occupancy of activatable states 
without desensitization, that is in the hypothetical case 
where M = 0 (smooth curves to the right in Figures 5B 
and 5C). The left boundary corresponds to occupancy of 
desensitized states without activation, that is with M very 
large (smooth curves through the binding data obtained 
in the presence of proadifen in Figures 58 and 5C). For 
wild-type AChR, the small value of M causes equilibrium 
binding to lie near the right of the concentration window, 
closer to that for binding solely to activatable states (Figure 
58). For aG153S AChR, the window is slightly smaller, 
owing to increased affinity of ACh for activatable states. 
However,  the major effect of aG153S is to cause equilib- 
rium binding to skew toward that for binding to the desensi- 
tized state, owing to the larger value of M. 
Discussion 
The initial report of the SCCMS revealed prolonged decay 
of miniature EP potentials despite normal abundance and 
kinetic properties of AChE, leading to the proposal that 
the mean open time of AChR was prolonged (Engel et al., 
1982). The findings presented here confirm the original 
proposal by demonstrating prolonged activation episodes 
at SCCMS EPs and, further, establish aG153S as a pri- 
mary cause of the syndrome by showing coincidence be- 
tween the disease and the mutation and by reconstituting 
the diseased AChR phenotype in an expression system. 
Analysis of the expressed mutant AChR shows that its 
prolonged activation episodes arise primarily from a de- 
creased rate of dissociation of ACh, allowing repetitive 
opening during ACh occupancy. Further, it is likely that 
an increased fraction of the mutant AChR will desensitize 
under conditions of raised ACh concentrations, such as 
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during repetitive stimulation of the motor synapse in the 
presence of AChE inhibitors (Magleby and Pallotta, 1981). 
Patch-clamp recordings from the SCCMS EPs showed 
open intervals of normal duration at all ACh concentrations 
examined, but analysis of burst durations revealed an ab- 
normally prolonged component of bursts. Pathogenicity 
of aG153S is therefore readily explained by increased re- 
openings of the AChR channel rather than by prolonged 
open channel intervals. Strikingly similar reopening be- 
havior was observed in the aG153S AChR expressed in 
HEKcells, which can now be taken as a kinetic signatureof 
the increased ACh binding affinity caused by the mutation. 
Also, clustering of channel activation episodes at the 
SCCMS EPs at raised concentrations of ACh was similar 
to that observed with aG153S AChR in the expression 
system. 
BecauseAChRsattheSCCMSEPscontain bothnormal 
and mutant a subunits, and because the two binding sites 
in the AChR are formed by as and a6 subunit pairs, as 
many as four types of AChRs could be present at these 
EPs. Differences in functional properties among these 
AChR types would be expected to introduce multiple com- 
ponents into the MEPC, ACh-induced noise, and single- 
channel recordings presented here and may also contrib- 
ute to differences in mean burst durations estimated by 
these different recording methods. For example, MEPCs 
decay with two detectable time constants of 8 ms  and 26 
ms  at the SCCMS EP, but single-channel burst durations 
show means of 3.4 and 13.3 ms, and noise analysis shows 
time constants of 1.8 and 12.3 ms. The continuous pres- 
ence of agonist in the single-channel and noise recordings 
may cause more strongly desensitizing AChR types to 
drop out early in the recording, decreasing their contribu- 
tion to the distribution of burst durations and the noise 
spectrum. Thus, AChR channel events that decay slowly 
following transient application of ACh (MEPC) may be less 
apparent during steady-state application in single-channel 
and noise recording. 
The key feature of the mutant AChR is its prolonged 
channel opening episodes. Analysis of these episodes at 
wide bandwidth revealed increased numbers of brief inter- 
ruptions per episode with little change in the open time 
between interruptions. Kinetic analysis of dwell t imes at 
low ACh concentrations disclosed rate constants for chan- 
nel opening (8) closing (a), and ACh dissociation (k-& Of 
these rate constants, only kez was greatly affected by the 
mutation, decreasing approximately Idfold. We obtained 
similar estimates of 8 and kmp over a range of raised ACh 
concentrations, and our estimate of a very fast 6 for wild- 
type AChR is similar to that obtained by kinetic analysis 
of Torpedo AChR (Sine et al., 1990) and to that obtained 
by fast ACh application experiments with mouse AChR 
(Maconochie and Steinbach, 1992, Biophys. Sot. Am. 
Sot. Biochem. Mol. Biol., abstract). Our experiments at 
raised ACh concentrations indicated increased rates of 
ACh association in the mutant, resulting in a 1 OO-fold net 
increase in affinity for one of the two binding sites (K, in 
Table 4). Further evidence for enhanced ACh binding in 
the mutant was increased affinity of the desensitized 
AChR for ACh (KR in Table 4). 
At first glance, the aG153S mutation appears structur- 
ally benign, despite conservation of G1.53 among a sub- 
units and the absence of glycine in homologous positions 
of the 6, y, 6, or E subunits. aG153 could, however, affect 
ACh binding affinity by its proximity to aW149, one of four 
aromatic residues identified by affinity labeling and muta- 
genesis to contribute to agonist binding affinity (Dennis 
et al., 1988). Containing only a hydrogen atom side chain, 
glycine can promote 6 turns and is part of a consensus 
sequence for terminating a helices (Aurora et al., 1994). 
Through one or more of these structural contributions, 
aG153 may affect positioning of aW149. Mutation to ser- 
ine may decrease local flexibility of the peptide chain or 
displace aW149 to allow improved interactions with ago- 
nist, thus increasing the rate of association and decreasing 
the rate of dissociation of ACh. It isof interest that aG153S 
appears to significantly affect only one of the two agonist 
binding sites, though it is present at both sites. This may 
be due to inherent differences in the binding sites caused 
by apposition of the a subunits to either the E or the 6 
subunit. 
The increased affinity caused by aG153S confirms the 
hypothesis that low ACh binding affinity is required for 
rapid termination of the synaptic response (Jackson, 
1989). According to the original description by Magleby 
and Stevens (1972) the decay of the EP current is due 
to properties intrinsic to the AChR rather than to removal 
of ACh from the synaptic cleft. The key intrinsic property 
is the duration of an activation episode following rapid 
binding and removal of ACh, which approximately equals 
the mean channel open time multiplied by the number of 
openings per activation episode, or (l/a)(l + f3/k-2) (Col- 
quhoun and Hawkes, 1981). Given avery fast 8 to provide 
rapid onset of the response, ke2 must be similarly rapid to 
limit the duration of the activation episode and thus allow 
repetitive generation of action potentials. Thus, the 15-fold 
decrease in km2 in the aG153S AChR causes a proportional 
increase in duration of the activation episode. 
The aG153S mutation can have multiple effects on neu- 
romuscular transmission. First, there may be reduced ex- 
pression of the mutant AChR; second, the prolonged EP 
currents cause cationic overloading and destructive 
changes at the EP (Engel et al., 1982); third, an increased 
fraction of the mutant AChR may become desensitized at 
physiological rates of stimulation (15-30 Hz) in the pres- 
ence of AChE inhibitors (Magleby and Pallotta, 1981); and 
fourth, even during normal physiologic activity, the pro- 
longed duration of the EP potential is likely to lead to their 
temporal summation and cause depolarization block of 
transmission. 
It is of interest that the SCCMS caused by the aG153S 
mutation is less clinically disabling than the previously re- 
ported ~T264P and sL269F mutations that also prolong 
channel activation episodes (Ohno et al., 1995a, 1995b). 
However, perhaps owing to their location in the M2 trans- 
membrane domain, cT264P and EL269F increase mean 
burst duration approximately 5-fold greater than aG153S 
which would cause more cationic overloading and explain 
why they are more deleterious than the aG153S mutation. 
To date, mutational analysis and patch-clamp studies 
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of CMS associated with prolonged open durations of AChR 
have revealed both genetic and phenotypic heterogeneity. 
It is now clear that the duration of EP currents can be 
altered by mutations affecting either the gating mecha- 
nism directly or the affinity of ACh for its binding site. Fi- 
nally, it is likely that other kinetically significant AChR sub- 
unit mutations causing CMS also exist, and that their study 
will yield further insights into structure-function relations 
of AChR. 
Experimental Procedures 
Clinical Data 
Patients 1 and 3 of this report were previously described as patients 
4 and 3 in the first description of the SCCMS (Engel et al., 1982). 
Patient 1, now 70 years old, had myasthenic symptoms since age 20. 
The family history is consistent with autosomal dominant inheritance 
through three generations. Patient 2 is the daughter of the affected 
brother of patient 1. She had myasthenic symptoms since age 3 but 
was undiagnosed until age 13. Patient 3 had myasthenic symptoms 
since age 34. His parents, five siblings, and two children were unaf- 
fected. Previous studies of intercostal muscle specimens in the 
SCCMS patients revealed an EP myopathy with degenerating junc- 
tional folds, EP AChR deficiency, abundant EP AChE, no kineticabnor- 
mality of muscle AChE, and normal to reduced amplitude and a pro- 
longed decay of the miniature potential (Engel et al., 1982). Control 
muscle specimens were obtained from patients without muscle dis- 
ease undergoing thoracic surgery. All human studies were in accord 
with the guidelines of the institutional Review Board of the Mayo Clinic. 
Electrophysiologic Studies in Patient 2 
An intercostal muscle specimen was used. All studies were done at 
22°C ? 0.5%. MEPCs were recorded using a two electrode voltage 
clamp by standard methods (Magleby and Stevens, 1972). MEPCs 
stored on videotape were low pass filtered at 500 Hz (-3 dB; 8 pole 
Bessel) and analyzed using an INDEC data acquisition and analysis 
system (INDEC, Sunnyvale, CA). MEPCs with <I ms rise times were 
accepted for analysis. The MEPC decay time constant was obtained 
from a computer fit of the curve y, = y&“’ to the decay phase, where 
y0 is the peak amplitude, T is the decay time constant, and t is time. 
Analysis of ACh induced current noise was performed by standard 
methods: the mean duration of channel events was derived from the 
noise power spectrum (Anderson and Stevens, 1973). 
Patch-Clamp Recordings from EP AChRs 
These were performed in the cell-attached configuration by a slight 
modification of the previously described method (Milone et al., 1994). 
The bath and pipette solutions contained 135 mM NaCI, 5 mM KCI, 
2 mM CaC&, 1 mM MgCI,, 15 mM NaHC03, 1.3 mM Na*HPO,, 11.1 
mM dextrose (pH 7.2), with the pipette solution containing specified 
concentrations of ACh. For all patches, the membrane potential was 
set to -80 mV; when possible, recordings were also obtained at -40, 
-120, and -160 mV. These membrane potentials were achieved by 
applying a corresponding positive potential to the patch pipette and 
assuming a resting potential of 0 mV; a null resting potential was 
confirmed by the absence of detectable channel events with 0 mV 
applied to the pipette. Channel currents were recorded at 50 kHz using 
the Axopatch 200A amplifier (Axon Instruments, Foster City, CA), digi- 
tized at 100 kHz. stored on hard disk, and analyzed using pClamp 6 
software (Axon Instruments) at a final bandwidth of 12 kHz. Burst 
durationsweredetermined bygroupingopeningsseparated byaspec- 
ified closed time (120-150 vs), which was taken as the intersection 
of the briefest closed time component with the next longer component. 
Open interval and burst duration histograms were plotted on logarith- 
mic abscissa and fitted to the sum of exponentials by maximum likeli- 
hood (Sigworth and Sine, 1987). 
mRNA and DNA Samples 
mRNA was obtained, using the Micro-FastTrack mRNA isolation kit 
(Invitrogen), from muscle specimens that had been stored under liquid 
nitrogen. First-strand cDNA was prepared from mRNA by using ran- 
dom hexamer primers with the cDNA Cycle kit (Invitrogen) and follow- 
mg the instructions of the manufacturer. Genomic DNA was isolated 
from blood lysate or from proteinase/SDS digest of muscle by phenol- 
chloroform extraction followed by ethanol precipitation (Sambrook et 
al., 1989). 
PCR Primers 
Published cDNA sequences of the human (x (Noda et al., 1963), b 
(Beeson et al., 1989), 6 (Luther et al., 1989), and E (Beeson et al., 
1993) subunit were used to design cDNA primers. To amplify each 
exon and its adjacent splice donor and acceptor sequences from geno- 
mic DNA of each AChR subunit, we synthesized PCR primers ac- 
cording to intron sequences. For this, we used the known genomic 
sequence of the a subunit (Noda et al., 1983) but determined intron 
sequences of the b, 6, and E subunit genes first by using cDNA primers 
adjacent to putative introns predicted from genomic organizations in 
other mammals and then by sequencing the PCR-amplif ied intron re- 
gions. For the first exon of the p, 6, and E subunits genes, we used 
inverse PCR (Huang et al., 1990) to extend sequence information 5’ 
to the translational start sites, and obtained S-end sequences for 142 
bp of the 8, 196 bp of the S, and 562 bp of the E subunit genes (data 
not shown). This information enabled us to synthesize PCR primers 
to amplify each exon of the a, p, 6, and E subunit genes. 
PCR Procedures 
PCR conditions for each primer were optimized by varymg Mg2’ con- 
centrationand pH and byaddition of 10%dimethylsulfoxideforamplifi- 
cation of G  + C-rich fragments. The typical PCR reaction mixture in- 
cluded 60 mM Tris-HCI (pH 8.5), 15 mM (NH&S04, 1.5-2 mM MgCI,, 
0.10-0.25 mM each dNTP, 0.8 KM each primer, with 100 ng of DNA 
and 1.25 U of Taq DNA polymerase (Perkin-Elmer/Cetus) in 50 ~1. 
cDNA fragments were amplified by the nested PCR procedure using 
l/50 of the first amplification product. The typical cycling protocol con- 
sisted of the following: first, denaturation at 94°C for 2 min; second, 
35 cycles of 94“C for 30 s, 55°C or 60°C for 30 s, 72% for 3 min; 
and third. final extension at 72°C for 7 min. 
SSCP Analysis 
The cold SSCP procedure was employed (Hongyo et al., 1993) with 
about 500 ng of PCR-amplif ied DNA. Denatured SSCP samples were 
loaded on a 40/o-20% gradient polyacrylamide gel, electrophoresed at 
12”C, stained with ethidium bromide, and examined under ultraviolet 
light. 
Sequence Analysis 
PCR-amplif ied fragments of genomic DNA or cDNA were used for all 
sequencing procedures. PCR amplification products were purified by 
Wizard PCR Prep (Promega). All fragments were sequenced with an 
Applied Biosystems model 373A DNA sequencer using fluorescently 
labeled dideoxy terminators. 
Restriction Enzyme Analysis 
A 155 bp fragments of genomic DNA spanning the aG153S mutation 
was amplified with primers 5’ATCATCGTCACCCACTTTCC-3’and 5’. 
AGTTGGAGACCCGAATCAC-3’. The PCR product (25 ul) was purified 
by ethanol precipitation. Restriction enzyme digestion was carried out 
by incubating the purified PCR product, 2 pl of IO x reaction buffer 
(SURE/Cut A, Boehringer-Mannheim), and 5 U Alul (Boehringer- 
Mannheim) in a volume of 20 ~1 at 37% for 2 hr. The products were 
size-fractionated on a 4% agarose gel containing ethidium bromide, 
Construction and Expression of Wild-Type and Mutant AChR 
Mouse AChR subunit cDNAs were generously provided by Drs. John 
Merlie, Norman Davidson (a, 8, and S subunits; referenced in Sine, 
1993), and Paul Gardner (E subunit; referenced in Bouzat et al., 1994) 
and were subcloned into the CMV-based expression vector pRBG4 
as described (Sine, 1993). aG153S was constructed by first inserting 
a BamHl restriction site at codon 153 of the a subunit cDNA using 
PCR mutagenesis. The resulting construct was digested with BamHI, 
treated with mung bean nuclease, and a synthetic double-stranded 
oligonucleotide harboring the G153S mutation was used to bridge from 
a 5’ Pstl site to the blunted BamHl site. The presence of the mutation 
and the absence of unwanted mutations was confirmed by dideoxy 
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sequencing. Human embryonic kidneyfibroblast cells (293 HEK)were 
transfected with mutant or wild-type AChR subunit cDNAs using cal- 
cium phosphate precipitation as described (Bouzat et al.,1994). 
Patch-Clamp Recordings from AChRs Expressed in HEK Cells 
Recordings were obtained in the cell-attached configuration (Hamill 
et al., 1981) at a membrane potential of -70 mV and at 22°C (Bouzat 
et al., 1994). The bath and pipette solutions contained 142 mM KCI, 
5.4 mM NaCI, 1.8 mM CaCI,, 1.7 mM MgCI,, and 10 mM HEPES buffer 
(pH 7.4). Because the aG153S AChR exhibited profound desensitiza- 
tion, single-channel currents at ACh concentrations greater than 300 
nM disappeared within the first minute after forming the seal. We 
found, however, that depolarizing at f70 mvforafew minutes restored 
activity and allowed events to be observed on return to -70 mV. Thus, 
at 1 and 10 KM ACh for aG153S, recordings were obtained with in- 
tervening pulses to +70 mV. We consistently observed a similar volt- 
age dependence for wild-type AChR at raised ACh concentrations, 
though less profound. Single-channel currents were recorded at 50 
kHz using the Axopatch 200A, and digitized at 94 kHz with a PCM 
adapter (VR-106, Instrutech). For analysis of measurements at low 
ACh concentrations, data were transferred to a Macintosh computer 
using the program VCATCH, and analyzed using the program MacTAC 
(Instrutech) at a final bandwidth of 12-14 kHz. To measure closed 
times near the instrumentation dead time, the digitized points were 
interpolated to determine the exact time of crossing the detection 
threshold, and the observed duration at threshold was corrected ac- 
cording to the filter bandwidth (Colquhoun and Sigworth, 1983). For 
recordings obtained at low ACh concentrations, dead times of 15.8 
and 12.5 ns were imposed for filter bandwidths of 12 and 14 kHz, 
respectively. The resulting open and closed time histograms were 
plotted using a logarithmic abscissa and a square root ordinate (Sig- 
worth and Sine, 1987) and fitted to the sum of exponentials by maxi- 
mum likelihood. Burst durations were determined by grouping open- 
ings separated by a specified closed time (loo-150 ps), which was 
taken as the intersection of the briefest closed time component with 
the next longer component. For analysis of recordings at raised ACh 
concentrations, clusters of openings were first identified using a closed 
time 5 times longer than the predominant closed time component in 
the recording. Channel openings and closings within clusters were 
then detected using the Viterbi algorithm (Chung et al., 1990); for 
wild-type AChR at 20 9M ACh, recordings were filtered at IO kHz, and 
the imposed dead time was 25 tus; for aG153S AChR at 0.3 to IO PM 
ACh, recordings were filtered at 14 kHz and the dead time was 15 ps. 
Channel events were analyzed according to scheme 2 by an interval- 
based maximum likelihood method that incorporated first order correc- 
tions for missed events (Roux and Sauve, 1985; see Zhang et al., 
1995). 
ACh Binding Measurements 
At 3 days after transfection, intact cells were harvested by gentle agita- 
tion in PBS plus 5 mM EDTA. The esterase inhibitor 3,3-dimethylbutyl 
methylphosphofluoridate(1 pM)was added tothe PBSIEDTAsolution, 
and cells were incubated for 15 min. Cells were briefly centrifuged, 
resuspended in high potassium Ringer’s solution, and divided into 
aliquots for ACh binding measurements. Specified concentrations Of 
ACh were added 30 min prior to addition of ‘251-labeled a-bungarotoxin, 
which was allowed to bind for 30 min to occupy at most half of the 
surface receptors. Unbound toxin was removed by washing twice with 
potassium Ringers solution containing 300 uM d-tubocurarine, fol- 
lowed by centrifugation, and radioactivity bound to the cells was mea- 
sured with a gamma counter. Nonspecific binding’was determined in 
the presence of 300 pM d-tubocurarine. The initial rate of toxin binding 
was determined to yield fractional occupancy of sites by ACh (Sine and 
Taylor, 1979). Binding data were analyzed according to the following 
binding function derived from scheme 2, 
Y = (Alterm I] + A2[term 2])/(1 + M  + PA[term I] + A*[term 21) (1) 
where A is the concentration of ACh. term 1 = 1/2K1 + 112K2 + MI 
Kk., term 2 = 1/KIK2 + M/K!+? + 6/a/K,K2, K1 = k-]/k+,, and Kz = k-2/ 
ki2 (Sine and Claudio, 1991). 
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